一些血友病患者是如何产生抑制物的？
How do some haemophiliacs develop inhibitors?
作者信息
Vermylen J
机构信息
Centre for Molecular and Vascular Biology, University of Leuven, Belgium.
出版信息
Haemophilia. 1998 Jul;4(4):538-42. doi: 10.1046/j.1365-2516.1998.440538.x.
Abstract
The purpose of this presentation is to concentrate on three issues: Is there an explanation for the large difference in reported incidence rates of inhibitor formation in haemophiliacs? Why do not all severe patients develop inhibitors? And how on the contrary do some patients with mild haemophilia develop inhibitors?
摘要
本报告的目的是聚焦于三个问题
对于血友病患者中报道的抑制剂形成发生率的巨大差异，是否存在一种解释？为什么并非所有重症患者都会产生抑制剂？相反，一些轻度血友病患者又是如何产生抑制剂的？
Zotero 插件